Back to
Envestnet Portfolio Solutions, Inc.
NKTR
Showing 0 of 4 quarters
Position history for
Envestnet Portfolio Solutions, Inc.'s holdings in NEKTAR THERAPEUTICS
No. Envestnet Portfolio Solutions exited its NKTR (Nektar Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 11,686 shares worth $10,917. Envestnet Portfolio Solutions already held NKTR in its Q3 2023 13F, the earliest on record, and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.